A Yeast Cell Wall Derived Hybrid Hydrogel with Photothermal and Immune Combined Modality Therapy for Enhanced Anti-Melanoma Efficacy

References

• Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 2011;16(1):5–24. doi:10.1634/theoncologist.2010-0190
   PubMed Web of Science ®Google Scholar
• Li C, Chi S, Xie J. Hedgehog signaling in skin cancers. Cell Signal. 2011;23(8):1235–1243. doi:10.1016/j.cellsig.2011.03.002
   PubMed Web of Science ®Google Scholar
• Mattia G, Puglisi R, Ascione B, Malorni W, Carè A, Matarrese P. Cell death-based treatments of melanoma: conventional treatments and new therapeutic strategies. Cell Death Dis. 2018;9(2):112. doi:10.1038/s41419-017-0059-7
   PubMedGoogle Scholar
• Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer. 2010;46(2):270–283. doi:10.1016/j.ejca.2009.10.032
   PubMed Web of Science ®Google Scholar
• Harries M, Malvehy J, Lebbe C, et al. Treatment patterns of advanced malignant melanoma (stage III–IV) – a review of current standards in Europe. Eur J Cancer. 2016;60:179–189. doi:10.1016/j.ejca.2016.01.011
   PubMed Web of Science ®Google Scholar
• Bhatia S, Tykodi SS, Thompson JA. Treatment of metastatic melanoma: an overview. Oncology. 2009;23(6):488–496.
   PubMed Web of Science ®Google Scholar
• Payandeh Z, Yarahmadi M, Nariman-Saleh-Fam Z, et al. Immune therapy of melanoma: overview of therapeutic vaccines. J Cell Physiol. 2019;234:14612–14621. doi:10.1002/jcp.28181
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Herrera-Bravo J, et al. The effects of thymoquinone on pancreatic cancer: evidence from preclinical studies. Biomed Pharmacother. 2022;153:113364. doi:10.1016/j.biopha.2022.113364
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Herrera-Bravo J, et al. Papaver plants: current insights on phytochemical and nutritional composition along with biotechnological applications. Oxid Med Cell Longev. 2022;2022:2041769. doi:10.1155/2022/2041769
   PubMed Web of Science ®Google Scholar
• Shao J, Xie H, Huang H, et al. Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy. Nat Commun. 2016;7(1):12967. doi:10.1038/ncomms12967
   PubMed Web of Science ®Google Scholar
• Heidari M, Sattarahmady N, Azarpira N, Heli H, Mehdizadeh AR, Zare T. Photothermal cancer therapy by gold-ferrite nanocomposite and near-infrared laser in animal model. Lasers Med Sci. 2016;31(2):221–227. doi:10.1007/s10103-015-1847-x
   PubMed Web of Science ®Google Scholar
• Shirata C, Kaneko J, Inagaki Y, et al. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress. Sci Rep. 2017;7(1):13958. doi:10.1038/s41598-017-14401-0
   PubMedGoogle Scholar
• Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7(1):13193. doi:10.1038/ncomms13193
   PubMed Web of Science ®Google Scholar
• Yoon H-J, Lee H-S, Lim J-Y, Park J-H. Liposomal indocyanine green for enhanced photothermal therapy. ACS Appl Mater Interfaces. 2017;9(7):5683–5691. doi:10.1021/acsami.6b16801
   PubMed Web of Science ®Google Scholar
• Nam J, Son S, Ochyl LJ, Kuai R, Schwendeman A, Moon JJ. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nat Commun. 2018;9(1):1074. doi:10.1038/s41467-018-03473-9
   PubMed Web of Science ®Google Scholar
• Shi H, Cao T, Connolly JE, et al. Hyperthermia enhances CTL cross-priming. J Immunol. 2006;176(4):2134–2141. doi:10.4049/jimmunol.176.4.2134
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Sheen MR, Zhang P, et al. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors. Nanomedicine. 2014;10(6):1273–1285. doi:10.1016/j.nano.2014.01.011
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Herrera-Bravo J, et al. The pharmacological activities of crocus sativus L.: a review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev. 2022;2022:8214821. doi:10.1155/2022/8214821
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Herrera-Bravo J, et al. A review on Tradescantia: phytochemical constituents, biological activities and health-promoting effects. Front Biosci. 2022;27(6):197. doi:10.31083/j.fbl2706197
   Web of Science ®Google Scholar
• Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14(8):463–482. doi:10.1038/nrclinonc.2017.43
   PubMed Web of Science ®Google Scholar
• Knight A, Karapetyan L, Kirkwood JM. Immunotherapy in Melanoma: recent advances and future directions. Cancers. 2023;15(4):1106. doi:10.3390/cancers15041106
   PubMed Web of Science ®Google Scholar
• Butnariu M, Quispe C, Koirala N, et al. Bioactive effects of curcumin in human immunodeficiency virus infection along with the most effective isolation techniques and type of nanoformulations. Int J Nanomedicine. 2022;17:3619–3632. doi:10.2147/IJN.S364501
   PubMed Web of Science ®Google Scholar
• Li X, Naylor MF, Le H, et al. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients. Cancer Biol Ther. 2010;10(11):1081–1087. doi:10.4161/cbt.10.11.13434
   PubMed Web of Science ®Google Scholar
• Aikins ME, Xu C, Moon JJ. Engineered nanoparticles for cancer vaccination and immunotherapy. Acc Chem Res. 2020;53(10):2094–2105. doi:10.1021/acs.accounts.0c00456
   PubMed Web of Science ®Google Scholar
• Lizée G, Radvanyi LG, Overwijk WW, Hwu P. Immunosuppression in melanoma immunotherapy: potential opportunities for intervention. Clin Cancer Res. 2006;12(7):2359s–2365s. doi:10.1158/1078-0432.CCR-05-2537
   PubMed Web of Science ®Google Scholar
• Mansfield AS, Holtan SG, Grotz TE, et al. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol. 2011;24(4):487–494. doi:10.1038/modpathol.2010.227
   PubMed Web of Science ®Google Scholar
• Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton AN. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene. 2003;22(20):3180–3187. doi:10.1038/sj.onc.1206462
   PubMed Web of Science ®Google Scholar
• Lin MJ, Svensson-Arvelund J, Lubitz GS, et al. Cancer vaccines: the next immunotherapy frontier. Nat Cancer. 2022;3(8):911–926. doi:10.1038/s43018-022-00418-6
   PubMedGoogle Scholar
• Shao K, Singha S, Clemente-Casares X, Tsai S, Yang Y, Santamaria P. Nanoparticle-based immunotherapy for cancer. ACS Nano. 2015;9(1):16–30. doi:10.1021/nn5062029
   PubMed Web of Science ®Google Scholar
• Leleux J, Roy K. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv Healthcare Mater. 2013;2(1):72–94. doi:10.1002/adhm.201200268
   Web of Science ®Google Scholar
• Wilson JT, Keller S, Manganiello MJ, et al. pH-responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano. 2013;7(5):3912–3925. doi:10.1021/nn305466z
   PubMed Web of Science ®Google Scholar
• Kang XM, Lei JX, Yang C, et al. A hybrid hydrogel composed of chitin and beta-glucan for the effective management of wound healing and scarring. Biomater Sci. 2022;10(20):6024–6036.
   PubMed Web of Science ®Google Scholar
• Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2:25. doi:10.1186/1756-8722-2-25
   PubMed Web of Science ®Google Scholar
• Elieh Ali Komi D, Sharma L, Dela Cruz CS. Chitin and its effects on inflammatory and immune responses. Clin Rev Allergy Immunol. 2018;54(2):213–223. doi:10.1007/s12016-017-8600-0
   PubMed Web of Science ®Google Scholar
• Jiang X, Bao H, Merzendorfer H, Yang Q. Immune responses of mammals and plants to chitin-containing pathogens. Adv Exp Med Biol. 2019;1142:61–81.
   PubMed Web of Science ®Google Scholar
• Xu X, Yasuda M, Nakamura-Tsuruta S, Mizuno M, Ashida H. β-glucan from lentinus edodes inhibits nitric oxide and tumor necrosis factor-α production and phosphorylation of mitogen-activated protein kinases in lipopolysaccharide-stimulated murine RAW 264.7 macrophages*. J Biol Chem. 2012;287(2):871–878. doi:10.1074/jbc.M111.297887
   PubMed Web of Science ®Google Scholar
• De Marco Castro E, Calder PC, Roche HM. β-1,3/1,6-glucans and immunity: state of the art and future directions. Mol Nutr Food Res. 2021;65(1):e1901071. doi:10.1002/mnfr.201901071
   PubMed Web of Science ®Google Scholar
• Albeituni SH, Yan J. The effects of β-glucans on dendritic cells and implications for cancer therapy. Anticancer Agents Med Chem. 2013;13(5):689–698. doi:10.2174/1871520611313050003
   PubMed Web of Science ®Google Scholar
• Yang R, Xu J, Xu L, et al. Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. ACS Nano. 2018;12(6):5121–5129. doi:10.1021/acsnano.7b09041
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhang S, Qin J, Wang J. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment. Acta Pharm Sin B. 2018;8(1):14–22. doi:10.1016/j.apsb.2017.11.009
   PubMed Web of Science ®Google Scholar
• Kang X, Lei J, Yang C, et al. A hybrid hydrogel composed of chitin and β-glucan for the effective management of wound healing and scarring. Biomater Sci. 2022;10(20):6024–6036. doi:10.1039/D2BM00935H
   PubMed Web of Science ®Google Scholar
• Chen Q, Huang G, Wu W, et al. A hybrid eukaryotic-prokaryotic nanoplatform with photothermal modality for enhanced antitumor vaccination. Adv Mater. 2020;32(16):e1908185. doi:10.1002/adma.201908185
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–2188. doi:10.1021/nl500618u
   PubMed Web of Science ®Google Scholar
• Ossio R, Roldán-Marín R, Martínez-Said H, Adams DJ, Robles-Espinoza CD. Melanoma: a global perspective. Nat Rev Cancer. 2017;17(7):393–394. doi:10.1038/nrc.2017.43
   PubMed Web of Science ®Google Scholar
• Ahmed EM. Hydrogel: preparation, characterization, and applications: a review. J Adv Res. 2015;6(2):105–121. doi:10.1016/j.jare.2013.07.006
   PubMed Web of Science ®Google Scholar
• Schoenmakers DC, Rowan AE, Kouwer PHJ. Crosslinking of fibrous hydrogels. Nat Commun. 2018;9(1):2172. doi:10.1038/s41467-018-04508-x
   PubMedGoogle Scholar
• Zidek J, Milchev A, Jancar J, Vilgis TA. Deformation-induced damage and recovery in model hydrogels – a molecular dynamics simulation. J Mech Phys Solids. 2016;94:372–387. doi:10.1016/j.jmps.2016.05.013
   Web of Science ®Google Scholar
• Jeon O, Song SJ, Lee K-J, et al. Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities. Carbohydr Polym. 2007;70(3):251–257. doi:10.1016/j.carbpol.2007.04.002
   Web of Science ®Google Scholar
• Taylor DL, in het Panhuis M. Self-Healing Hydrogels. Adv Mater. 2016;28(41):9060–9093. doi:10.1002/adma.201601613
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang Y, Li X, et al. Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy. ACS Nano. 2019;13(10):11967–11980. doi:10.1021/acsnano.9b06040
   PubMed Web of Science ®Google Scholar
• Ni JS, Zhang X, Yang G, et al. A photoinduced nonadiabatic decay-guided molecular motor triggers effective photothermal conversion for cancer therapy. Angew Chem Int Ed Engl. 2020;59(28):11298–11302. doi:10.1002/anie.202002516
   PubMed Web of Science ®Google Scholar
• Rao L, G-t Y, Meng Q-F, et al. Cancer cell membrane-coated nanoparticles for personalized therapy in patient-derived xenograft models. Adv Funct Mater. 2019;29(51):1905671. doi:10.1002/adfm.201905671
   Web of Science ®Google Scholar
• Luo L, Zhu C, Yin H, et al. Laser immunotherapy in combination with perdurable PD-1 blocking for the treatment of metastatic tumors. ACS Nano. 2018;12(8):7647–7662. doi:10.1021/acsnano.8b00204
   PubMed Web of Science ®Google Scholar
• Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4(33). doi:10.1126/sciimmunol.aau6085
   PubMed Web of Science ®Google Scholar
• Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–616.
   PubMed Web of Science ®Google Scholar
• Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125(9):3335–3337. doi:10.1172/JCI83871
   PubMed Web of Science ®Google Scholar
• Thakur A, Kondadasula SV, Ji K, et al. Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE). Cancer Immunol Immunother. 2021;70(3):633–656. doi:10.1007/s00262-020-02692-8
   PubMed Web of Science ®Google Scholar
• Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002;2(4):251–262. doi:10.1038/nri778
   PubMed Web of Science ®Google Scholar
• Kennedy R, Celis E. Multiple roles for CD4+ T cells in anti-tumor immune responses. Immunol Rev. 2008;222:129–144. doi:10.1111/j.1600-065X.2008.00616.x
   PubMed Web of Science ®Google Scholar
• Salti SM, Hammelev EM, Grewal JL, et al. Granzyme B regulates antiviral CD8+ T cell responses. J Immunol. 2011;187(12):6301–6309. doi:10.4049/jimmunol.1100891
   PubMed Web of Science ®Google Scholar